Skip to main content
. 2017 Oct 4;12(10):e0185449. doi: 10.1371/journal.pone.0185449

Fig 1. Changes in bone mineral disorder biomarkers, ADMA and SDMA according to the treatment group (paricalcitol/placebo).

Fig 1

The bars correspond to 95%CI.